Gencove

New York, NY · Founded 2015 · Privately Held (backing)

Developer of a sequencing platform designed to make whole-genome sequencing fast, affordable, and actionable. Gencove is based in New York, NY and was founded in 2015. It was valued at $50 million at its later-stage round in Oct 2021, the last priced event on record. It has raised $16 million across 3 recorded rounds; the latest was a $9.8 million early-stage round in Oct 2021.

PMV mark · valuation
$50.0M
Oct 2026
Priced at
its later-stage round
Oct 2021
Total raised
$16.0M
Last round
Early Stage VC
Oct 2021

Who backs Gencove?

13 investors
InvestorType
SV AngelVenture capital
Alexandria Venture InvestmentsOther
Refactor CapitalVenture capital
Third Kind Venture CapitalVenture capital
Spero VenturesVenture capital
Lewis & Clark PartnersGrowth equity
Bread & Butter Ventures—
Burst Capital—
Entrepreneurship Lab Bio & Health Tech NYC—
HBM Genomics—
+ 3 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Gencove investors

13 investors are on record for Gencove, including SV Angel, Alexandria Venture Investments, Refactor Capital and Third Kind Venture Capital. By type, the record holds 4 venture capital firms and 1 growth equity firm. The early-stage round in Oct 2021 drew 8 investors.

Free account
More of Gencove with a free account
  • ·The complete investor list: 13 names
  • ·Watch Gencove: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 13 firms already write checks for companies like Gencove. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View